<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180728040618N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-08-01</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effectiveness of traditional physiotherapy and High-Tone therapy vs.  routine physiotherapy alone on trigger point in upper trapezius muscle</public_title>
      <acronym></acronym>
      <scientific_title>The effectiveness of traditional physiotherapy and High-Tone therapy vs.  routine physiotherapy alone on pain, cervical ROM, disability level and quality of life  in chronic non-specific neck pain subjects with trigger point in upper trapezius muscle</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-16</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/57292</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients with nonspecific chronic neck pain are randomly divided into two groups: routine physiotherapy and high-tone therapy (group A) and routine physiotherapy group alone (B) with a ratio of 1:1. Random allocation will be done by the method of balanced (permuted) block randomization, which consists of 4-letter blocks and are made of letters A and B. Then, the treatment allocation list obtained in letters A and B is placed inside the numbered envelopes. The letter A stands for routine physiotherapy and high-tone therapy, and the letter B denotes routine physiotherapy alone. The random assignment process is performed by someone outside the research team before the study begins. Block randomization tool will be done by Random allocation software. After the initial evaluation of the patient by the examiner, the envelopes will be numbered according to the number of each person entered in the study. Finally, after each patient enters the treatment sessions, the intervention provider adjusts the treatment interventions based on the letters in the envelope, Blinding description: The assessor will be completely unaware of the letters inside the envelopes at the random assignment stage. It should also be noted that after placing patients in the desired group, they are asked not to provide their grouping information to the assessor. All assessments will be performed by a physiotherapist. This person does not know the grouping of patients with chronic non-specific neck pain. In other words, at the time of the final evaluation of the patients, the assessor is not able to determine what type of treatment each patient has received. Therapeutic interventions will be performed by another physiotherapist.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic non-specific neck pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Individuals with non-specific chronic neck pain who are in the routine physiotherapy and hightone therapy groups receive the same routine physiotherapy protocol twice a week for 4 weeks. In addition, individuals in the experimental group treated with hightone therapy. This study uses hightone currents with HITOP device (manufacturer: GBO   Country of manufacture: Germany), which produces currents with a pulse width of less than 350 mA and less than 70 volts. The current starts with an initial frequency of 4096 Hz and reaches a frequency of 32768 Hz in more than 3 seconds. At frequency 32768, the current is maintained for a maximum of 3 seconds and then returns to the base frequency, and the intensity of the current increases to such an extent that the person does not feel pain or discomfort. Individuals in the experimental group receive Hightone currents for 20 minutes per session, twice a week for 4 consecutive weeks. Intervention 2: Control group: Individuals with chronic non-specific neck pain who are placed in the routine physiotherapy group alone receive the following protocol twice a week for 4 weeks.1- Heat (using infrared light for 10 minutes at the beginning of treatment) 2- Acupuncture-like current (TENS) (due to chronic pain) with a frequency below 10 Hz, pulse duration 150-250 microseconds. Four electrodes (two channels) are placed on the neck area and the sore spot of the trigger points for 15 minutes. 3- Ischemic pressure technique on trigger points: To apply this technique, the person is placed in a prone position and the upper trapezius muscle is placed in a shortened position. This technique involves continuous deep pressure using the thumb, which gradually increases to the patient's tolerance threshold. The pressure is relieved when either a tissue release is felt under the contraction or it lasts more than 60 seconds. This technique is applied 3 times per session for each trigger point with a 10 second rest interval. 4- Upper Trapezius Muscle Stretching Training: To stretch the each side of upper trapezius muscle, asked while sitting facing on chair, to bend the neck forward, and lateral flex to the opposite side, and rotate towards the affected. People are asked to do this exercise three days a week, 2 times a day, 10 repetitions each time, and 30 seconds for the involved side.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Deidentified individual participant data collected for the primary and secondary outcome measures will be shared if necessary

When:
Starting 6 months after publication

To whom:
The data will be available for physical therapists working in academic institutions and also clinicians working in the field of musculoskeletal disorders

Conditions:
The raw data and results of this study can be used in future relevant systematic reviews. Thus, the raw data and results of this study will be available for researchers working in the field of hightone current and trigger points of upper trapzius muscle.

Where to obtain:
Applicants can contact the researcher of this study Zamane bonyatpour by email. Email address: zamane94@gmail.com

How to obtain:
Applicants should explain in detail about their project and how the data/documents of this study will be used in their project. Then, the data/documents files will be sent by email to applicants on request. This process may takes 10-12 working days.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Holako Mohsenifar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences of Iran University of Medical Sciences, Madadkaran St, Shah Nazari St, Madar Sq, Mirdamad Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 8670 2504</telephone>
        <email>Mohsenifarpt@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Holako Mohsenifar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation Sciences of Iran University of Medical Sciences, Madadkaran St, Shah Nazari St, Madar Sq, Mirdamad Blvd, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 7124</telephone>
        <email>Mohsenifarpt@gmail.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patient with chronic non-specific neck pain
Age between 20 to 50 years old
Ability to read and write in Persian</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Specific neck pain
History of migraine
Peripheral nerve involvement in shoulder and neck region
Existence of fractures in the spine
Existence of tumor in the spine
Existence of musculoskeletal disorders in shoulder region</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cervicalgia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Individuals with non-specific chronic neck pain who are in the routine physiotherapy and hightone therapy groups receive the same routine physiotherapy protocol twice a week for 4 weeks. In addition, individuals in the experimental group treated with hightone therapy. This study uses hightone currents with HITOP device (manufacturer: GBO   Country of manufacture: Germany), which produces currents with a pulse width of less than 350 mA and less than 70 volts. The current starts with an initial frequency of 4096 Hz and reaches a frequency of 32768 Hz in more than 3 seconds. At frequency 32768, the current is maintained for a maximum of 3 seconds and then returns to the base frequency, and the intensity of the current increases to such an extent that the person does not feel pain or discomfort. Individuals in the experimental group receive Hightone currents for 20 minutes per session, twice a week for 4 consecutive weeks.</i_keyword>
      <i_keyword>Control group: Individuals with chronic non-specific neck pain who are placed in the routine physiotherapy group alone receive the following protocol twice a week for 4 weeks.1- Heat (using infrared light for 10 minutes at the beginning of treatment) 2- Acupuncture-like current (TENS) (due to chronic pain) with a frequency below 10 Hz, pulse duration 150-250 microseconds. Four electrodes (two channels) are placed on the neck area and the sore spot of the trigger points for 15 minutes. 3- Ischemic pressure technique on trigger points: To apply this technique, the person is placed in a prone position and the upper trapezius muscle is placed in a shortened position. This technique involves continuous deep pressure using the thumb, which gradually increases to the patient's tolerance threshold. The pressure is relieved when either a tissue release is felt under the contraction or it lasts more than 60 seconds. This technique is applied 3 times per session for each trigger point with a 10 second rest interval. 4- Upper Trapezius Muscle Stretching Training: To stretch the each side of upper trapezius muscle, asked while sitting facing on chair, to bend the neck forward, and lateral flex to the opposite side, and rotate towards the affected. People are asked to do this exercise three days a week, 2 times a day, 10 repetitions each time, and 30 seconds for the involved side.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: Before the intervention and 4 weeks after the last treatment session. Method of measurement: visual analog scale.</prim_outcome>
      <prim_outcome>Neck range of motion. Timepoint: Before the intervention and 4 weeks after the last treatment session. Method of measurement: guniameter.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Neck disability. Timepoint: before the intervention and 4 weeks after the last treatment session. Method of measurement: neck disability index questionnaire.</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: before the intervention and 4 weeks after the last treatment session. Method of measurement: quality of life questionnaire SF-36.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-28</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
